Grünenthal GmbH
Grünenthal GmbH
Explore linked clinical trials.6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial of GRT7040 in Adults With Acute Pain Following Bunionectomy | Acute Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Not yet recruiting | Phase 2 | 2026-09-15 | NCT07807644 | |
| Chemotherapy Induced Peripheral Neuropathy by Taxanes and Capsaicin 8%. | Patients With Taxane-induced Chronic Neuropathic Pain | Recruiting | Not applicable | 2026-05-22 | NCT07602387 | |
| Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy | Chemotherapy-induced Peripheral Neuropathy | Recruiting | Phase 3 | 2026-03-31 | NCT05840562 | |
| A First-in-human Trial of GRT7041 in Healthy Participants | Treatment of Pain | Recruiting | Phase 1 | 2026-02-20 | NCT07289776 | |
| TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis | Recruiting | Phase 2 | 2025-06-29 | NCT03910738 | |
| Capsaicin in Digital Osteoarthritis Versus Control | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorder | Recruiting | Phase 4 | 2025-03-13 | NCT06444919 |